Medpace Holdings Gross Margin 2014-2024 | MEDP

Current and historical gross margin for Medpace Holdings (MEDP) over the last 10 years. The current gross profit margin for Medpace Holdings as of September 30, 2024 is %.
Medpace Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $2.07B $1.39B 67.29%
2024-06-30 $2.03B $1.36B 66.98%
2024-03-31 $1.96B $1.30B 66.46%
2023-12-31 $1.89B $1.25B 66.15%
2023-09-30 $1.78B $1.17B 65.47%
2023-06-30 $1.67B $1.09B 64.85%
2023-03-31 $1.56B $1.00B 64.11%
2022-12-31 $1.46B $0.93B 63.36%
2022-09-30 $1.38B $0.86B 62.69%
2022-06-30 $1.29B $0.80B 62.00%
2022-03-31 $1.21B $0.75B 61.70%
2021-12-31 $1.14B $0.70B 61.42%
2021-09-30 $1.09B $0.68B 62.16%
2021-06-30 $1.03B $0.64B 62.26%
2021-03-31 $0.96B $0.59B 61.57%
2020-12-31 $0.93B $0.57B 61.66%
2020-09-30 $0.90B $0.55B 61.05%
2020-06-30 $0.88B $0.54B 61.11%
2020-03-31 $0.89B $0.56B 62.40%
2019-12-31 $0.86B $0.54B 62.72%
2019-09-30 $0.82B $0.52B 63.18%
2019-06-30 $0.79B $0.50B 63.87%
2019-03-31 $0.74B $0.48B 64.15%
2018-12-31 $0.70B $0.45B 64.35%
2018-09-30 $0.63B $0.39B 61.76%
2018-06-30 $0.56B $0.33B 58.53%
2018-03-31 $0.49B $0.27B 54.97%
2017-12-31 $0.44B $0.22B 51.26%
2017-09-30 $0.43B $0.22B 51.85%
2017-06-30 $0.43B $0.22B 52.21%
2017-03-31 $0.43B $0.23B 52.91%
2016-12-31 $0.42B $0.22B 53.08%
2016-06-30 $0.30B $0.16B 53.69%
Sector Industry Market Cap Revenue
Medical Medical Services $10.202B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00